The iso-volume pressure support range: stable tidal volume conceals major physiological changes during pressure support ventilation

ISRCTN ISRCTN69141246
DOI https://doi.org/10.1186/ISRCTN69141246
Sponsor Le Groupe de Recherche Clinique CARMAS
Funder Investigator initiated and funded
Submission date
26/06/2026
Registration date
30/06/2026
Last edited
30/06/2026
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Other
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Samuel Tuffet
Principal investigator, Public, Scientific

20 quai Claude Bernard
LYON 06
69006
France

Phone +33478618210
Email stuffet@saintjosephsaintluc.fr

Study information

Primary study designInterventional
AllocationN/A: single arm study
MaskingOpen (masking not used)
ControlUncontrolled
AssignmentSingle
PurposeDiagnostic
Scientific titleThe iso-volume pressure support range: stable tidal volume conceals major physiological changes during pressure support ventilation
Study objectives To characterize the iso-volume pressure support range and evaluate the physiological consequences of pressure support modifications within its boundaries
Ethics approval(s)

Approved 09/07/2018, South West 3 Research Ethics Committee (Comité de protection des personnes Sud Ouest 3) (Groupe hospitalier Pellegrin, Place Amélie Raba Léon, Bordeaux, 33076, France; +33557817607; cpp.soom3@u-bordeaux.fr), ref: 2018-A00867-48

Health condition(s) or problem(s) studiedPatients invasively ventilated in pressure-support mode
InterventionA decremental pressure support titration is performed with steps of 2 cmH₂O, each lasting five minutes, from 20 to 4 cmH₂O. Sedation and analgesia levels are not modified during the titration. PEEP, FiO₂, trigger, pressurization slope, and the expiratory cycling criterion are kept constant as set by the clinician. Titration has to be interrupted in case of arterial hypotension, poor respiratory tolerance (SpO₂ below 88% despite a 20% increase in FiO₂, or respiratory rate above 40 breaths/min for one minute), or at the request of the patient or the physician in charge of the patient. Airway flow is recorded using an AC137A-1 pneumotachograph (Biopac Systems, Goleta, CA, USA) placed between the Y-piece and the endotracheal tube. Airway and esophageal pressures are measured using TSD160D transducers (Biopac Systems). All signals are acquired using AcqKnowledge® software (Biopac Systems, Goleta, CA, USA). EIT monitoring (Enlight 1800, Timpel, São Paulo, Brazil) is performed using a belt positioned around the chest at the fourth to fifth intercostal space. Total duration of the intervention was then 45 minutes for each patient.
Intervention typeProcedure/Surgery
Primary outcome measure(s)
  1. Tidal Volume measured using data collected from the ventilator screen at the decremental pressure support titration
Key secondary outcome measure(s)
Completion date31/12/2021

Eligibility

Participant type(s)
Age groupMixed
Lower age limit18 Years
Upper age limit100 Years
SexAll
Target sample size at registration17
Total final enrolment17
Key inclusion criteria1. Adult (age at least 18 years)
2. Invasively ventilated in pressure support mode
Key exclusion criteria1. Contra-indication to electrical impedance tomography
2. Pregnancy
3. Legal protection status
4. Refusal of the patient or next of kin
Date of first enrolment01/09/2018
Date of final enrolment31/12/2021

Locations

Countries of recruitment

  • France

Study participating centres

Results and Publications

Individual participant data (IPD) Intention to shareNo

Editorial Notes

30/06/2026: Study’s existence confirmed by the South West 3 Research Ethics Committee (Comité de protection des personnes Sud Ouest 3), France.